Clinical Trial Detail

NCT ID NCT02516553
Title BI 894999 First in Human Dose Finding Study in Advanced Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications

lung small cell carcinoma

NUT midline carcinoma

prostate carcinoma

Advanced Solid Tumor

diffuse large B-cell lymphoma

colorectal cancer

Therapies

BI 894999

Age Groups: adult senior

No variant requirements are available.